Fort Sanders Regional Medical Center Fort Sanders Regional Medical Center is a provider of health care services. | Alimentiv Alimentiv (formerly known as Robarts Clinical Trials) is a company that provides clinical research and imaging services for gastrointestinal and liver diseases. | ![]() iCAD iCAD is a company that specializes in developing AI-based solutions for early detection and risk assessment of breast cancer. | |||
Founding Date | Founding Date 1919 | Founding Date 1985 | Founding Date 2014 | Founding Date 1986 | Founding Date N/A |
Type | Type Private | Type Private | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Knoxville, US HQ | Locations HQ | Locations HQ | Locations London, CA HQ Toronto, CA Amsterdam, NL San Diego, US | Locations Nashua, US HQ San Jose, US |
Employees | Employees 5252% increase | Employees 58 | Employees N/A | Employees 5881% increase | Employees 6738% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 7.5 m | Valuation ($) N/A | Valuation ($) 50.1 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $19.6m (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $3m (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit $16.6m (FY, 2024) |
Net income | Net income N/A | Net income N/A | Net income ($2.7m) (FY, 2025) | Net income N/A | Net income ($5.6m) (FY, 2024) |
Diagnoson a+ is a company that operates as a clinical laboratory.
View companyTelo Genomics is a biotechnology company that provides technological products.
View companyAlimentiv (formerly known as Robarts Clinical Trials) is a company that provides clinical research and imaging services for gastrointestinal and liver diseases.
View company
iCAD is a company that specializes in developing AI-based solutions for early detection and risk assessment of breast cancer.
View company